Nuzyra 150 MG tablet UD 30S
Ended Awarded
- Contract number
- SPE2DB25FJ4JD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,072
Award facts
- Contract value 100% obligated
- $10,071.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $10,071.86 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 unit-dose tablets of Nuzyra 150 mg on August 26, 2025, with completion targeted for September 17, 2025. This is a competitive award with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor in the federal medical supply chain supporting military and veteran healthcare systems. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which provides comprehensive global pharmaceutical support across multiple therapeutic domains for defense healthcare programs worldwide.
Nuzyra (omadacycline) is a tetracycline-class antibiotic used to treat bacterial infections, and this procurement reflects the federal government's ongoing pharmaceutical needs for military medical operations. AmerisourceBergen's extensive portfolio of federal contract awards demonstrates its capability to fulfill diverse and specialized medical supply requirements through competitive procurement processes. The company's position as a prime vendor within the DLA Medical Supply Chain underscores its strategic importance to the Defense Health Agency and other federal healthcare entities in ensuring reliable access to essential pharmaceutical products.
Quick answers
Who was awarded contract SPE2DB25FJ4JD?
SPE2DB25FJ4JD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 26, 2025.
How much is contract SPE2DB25FJ4JD worth?
The government has obligated $10,072 on SPE2DB25FJ4JD.
Is contract SPE2DB25FJ4JD an order under another contract?
Yes. SPE2DB25FJ4JD is a delivery order under SPE2DB22D2007, an indefinite delivery contract.
Was contract SPE2DB25FJ4JD competed?
The extent of competition for SPE2DB25FJ4JD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award